166 related articles for article (PubMed ID: 23279825)
1. Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CT.
Sahoo MK; Gupta S; Singh I; Pahwa S; Durgapal P; Bal CS
Asia Pac J Clin Oncol; 2014 Jun; 10(2):190-3. PubMed ID: 23279825
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.
Mavi ME; Tuncel M
Clin Nucl Med; 2021 Dec; 46(12):1002-1003. PubMed ID: 34034327
[TBL] [Abstract][Full Text] [Related]
3. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
4. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
5. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
[TBL] [Abstract][Full Text] [Related]
6. Necrolytic migratory erythema.
Lee HJ; Jang YH
CMAJ; 2019 Mar; 191(10):E286. PubMed ID: 30858185
[No Abstract] [Full Text] [Related]
7. Visual Vignette.
Sathyakumar S; Cherian KE; Jebasingh F; Hepzhibah J; Kapoor N; Paul TV
Endocr Pract; 2017 Jan; 23(1):116. PubMed ID: 27631840
[No Abstract] [Full Text] [Related]
8. Glucagonoma syndrome associated with necrolytic migratory erythema.
Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
[TBL] [Abstract][Full Text] [Related]
9. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
10. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
11. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
Oberkirchner U; Linder KE; Zadrozny L; Olivry T
Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
[TBL] [Abstract][Full Text] [Related]
13. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.
Tamura A; Ogasawara T; Fujii Y; Kaneko H; Nakayama A; Higuchi S; Hashimoto N; Miyabayashi Y; Fujimoto M; Komai E; Kono T; Sakuma I; Nagano H; Suzuki S; Koide H; Yokote K; Iseki K; Oguma R; Matsue H; Nojima H; Sugiura K; Yoshitomi H; Ohtsuka M; Rahmutulla B; Kaneda A; Inoshita N; Ogawa S; Tanaka T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2417-2423. PubMed ID: 29688432
[TBL] [Abstract][Full Text] [Related]
14. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
15. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
16. Necrolytic migratory erythema and pancreatic glucagonoma.
Rodríguez G; Vargas E; Abaúnza C; Cáceres S
Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of (68)Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors.
Sharma P; Arora S; Dhull VS; Naswa N; Kumar R; Ammini AC; Bal C
Abdom Imaging; 2015 Feb; 40(2):299-309. PubMed ID: 25134801
[TBL] [Abstract][Full Text] [Related]
19. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
20. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
